NeuBase Therapeutics, Inc. Accrued Liabilities, Current
NeuBase Therapeutics, Inc. had Accrued Liabilities, Current of $462.19 thousand as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-11-09
- 2023-09-30: Accrued Liabilities, Current $462.19K.
- 2023-06-30: Accrued Liabilities, Current $1.05M.
- 2023-03-31: Accrued Liabilities, Current $800.57K.
- 2022-12-31: Accrued Liabilities, Current $1.23M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-09-30 | $462.19K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.05M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $800.57K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.23M 10-Q · filed 2023-11-09 | |
| 2022-09-30 | $1.66M 10-QT · filed 2023-06-05 | |
| 2022-06-30 | $1.87M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.70M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.41M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $1.75M 10-K · filed 2022-12-21 | |
| 2021-06-30 | $1.04M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $1.13M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.75M 10-Q · filed 2022-02-11 | $743.85K 10-Q · filed 2021-02-11 |
| 2020-09-30 | $555.88K 10-K · filed 2021-12-23 | |
| 2020-06-30 | $434.97K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $942.61K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $242.92K 10-Q · filed 2020-03-26 | |
| 2019-09-30 | $405.60K 10-K · filed 2020-12-23 | |
| 2018-09-30 | $19.81K 10-K · filed 2020-01-10 |